Target type: biologicalprocess
The removal of phosphoric residues from peptidyl-O-phospho-L-threonine to form peptidyl-threonine. [GOC:bf]
Peptidyl-threonine dephosphorylation is the removal of a phosphate group from a threonine residue within a protein. This process is catalyzed by a specific type of protein phosphatase known as a threonine-specific protein phosphatase. The phosphate group is typically attached to the hydroxyl group of the threonine side chain, forming a phosphothreonine residue. This phosphorylation event can alter the protein's conformation, activity, localization, or interactions with other proteins. Dephosphorylation reverses this modification, restoring the protein to its original state. The process begins when the protein phosphatase binds to the phosphorylated threonine residue. The enzyme then utilizes a nucleophilic attack by a water molecule, facilitated by the enzyme's active site residues, to break the phosphodiester bond between the phosphate group and the threonine. The phosphate group is released as inorganic phosphate (Pi) and the threonine residue is dephosphorylated. This dephosphorylation event can have significant regulatory effects on various cellular processes. For instance, it can activate or inactivate enzymes, regulate protein-protein interactions, control the localization of proteins, and influence cell signaling pathways. The precise role of peptidyl-threonine dephosphorylation depends on the specific protein and the context in which it occurs. Understanding the intricacies of this process is crucial for unraveling the complexity of cellular regulation and for developing therapeutic strategies targeting protein phosphorylation.'
"
Protein | Definition | Taxonomy |
---|---|---|
Dual specificity protein phosphatase 5 | A dual specificity protein phosphatase 5 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q16690] | Homo sapiens (human) |
Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform | A serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform that is encoded in the genome of human. [PRO:CNA, UniProtKB:P67775] | Homo sapiens (human) |
Serine/threonine-protein phosphatase 5 | A serine/threonine-protein phosphatase 5 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P53041] | Homo sapiens (human) |
Protein phosphatase 1A | A protein phosphatase 1A that is encoded in the genome of human. [PRO:DNx, UniProtKB:P35813] | Homo sapiens (human) |
Protein phosphatase 1B | A protein phosphatase 1B that is encoded in the genome of human. [PRO:DNx, UniProtKB:O75688] | Homo sapiens (human) |
Protein phosphatase 1D | A protein phosphatase 1D that is encoded in the genome of human. [PRO:DNx, UniProtKB:O15297] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
suramin | suramin : A member of the class of phenylureas that is urea in which each of the amino groups has been substituted by a 3-({2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl}carbamoyl)phenyl group. An activator of both the rabbit skeletal muscle RyR1 and sheep cardiac RyR2 isoform ryanodine receptor channels, it has been used for the treatment of human African trypanosomiasis for over 100 years. Suramin: A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties. | naphthalenesulfonic acid; phenylureas; secondary carboxamide | angiogenesis inhibitor; antinematodal drug; antineoplastic agent; apoptosis inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; GABA antagonist; GABA-gated chloride channel antagonist; purinergic receptor P2 antagonist; ryanodine receptor agonist; trypanocidal drug |
cantharidin | cantharidin : A monoterpenoid with an epoxy-bridged cyclic dicarboxylic anhydride structure secreted by many species of blister beetle, and most notably by the Spanish fly, Lytta vesicatoria. Natural toxin inhibitor of protein phosphatases 1 and 2A. Cantharidin: A toxic compound, isolated from the Spanish fly or blistering beetle (Lytta (Cantharis) vesicatoria) and other insects. It is a potent and specific inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A). This compound can produce severe skin inflammation, and is extremely toxic if ingested orally. | cyclic dicarboxylic anhydride; monoterpenoid | EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; herbicide |
nsc-87877 | NSC-87877: potent Shp2 (nonreceptor protein tyrosine phosphatase) inhibitor; structure in first source | ||
cyanoginosin lr | cyanoginosin LR: cyclic heptapeptide from cyanobacterium Microcystis aeruginosa microcystin-LR : A microcystin consisting of D-alanyl, L-leucyl, (3S)-3-methyl-D-beta-aspartyl,L-arginyl, 2S,3S,4E,6E,8S,9S)-3-amino-4,5,6,7-tetradehydro-9-methoxy-2,6,8-trimethyl-10-phenyldecanoyl, D-gamma-glutamyl, and 2,3-didehydro-N-methylalanyl residues joined into a 25-membered macrocycle. Produced by the cyanobacterium Microcystis aeruginosa, it is the most studied of the microcystins. | microcystin | bacterial metabolite; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; environmental contaminant; xenobiotic |
okadaic acid | polycyclic ether | calcium ionophore; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; marine metabolite | |
cefsulodin | cefsulodin : A pyridinium-substituted semi-synthetic, broad-spectrum, cephalosporin antibiotic. Cefsulodin: A pyridinium-substituted semisynthetic, broad-spectrum antibacterial used especially for Pseudomonas infections in debilitated patients. | cephalosporin; organosulfonic acid; primary carboxamide | antibacterial drug |
cyanoginosin-la | cyanoginosin-LA: from cyanobacterium Microcystis aeruginosa | peptide | |
demethylcantharidin | demethylcantharidin: has antineoplastic activity; structure in first source | ||
gsk2830371 | GSK2830371: inhibits Wip1 phosphatase; structure in first source |